GENEQUALITY 2050 - A COMPREHENSIVE AUTOMATION SOLUTION FROM AB ANALITICA
The GeneQuality 2050 system - a comprehensive automation solution from AB Analitica, delivering outstanding performance in real-time PCR testing with speed, accuracy, and safety.
REAL-TIME PCR TESTING AND THE AUTOMATION TREND
Real-time PCR testing is a molecular biology technique used to amplify and detect the DNA/RNA of a target pathogen. This method is extremely sensitive and particularly useful in infectious disease diagnosis, gene mutation detection, and genetic research.
Today, automation is an inevitable trend for increasing testing efficiency and minimizing errors. Automated systems offer:
- - Faster processing, shortening the "sample-to-result" time.
- - Fewer manual steps, increasing efficiency and avoiding the risk of contamination.
- - Simultaneous processing of multiple samples with consistent and reliable results.
CONSIDERATIONS WHEN CHOOSING AN AUTOMATED TESTING SYSTEM
- - Full automation from sample to result. All steps are fully integrated: extraction, PCR amplification, and result analysis. This helps optimize time and minimize errors.
- - Ability to process a wide range of sample matrices
- - Support for primary sample tubes of various sizes, helping optimize the workflow. This is especially important for laboratories handling varied sample volumes.
- - Ability to perform multiple types of tests (quantitative, qualitative) in a single run, saving time and resources.
- - Automatic result reading and analysis
- - Integrated automatic analysis, LIMS support, and fast, accurate results that reduce workload and ensure data reliability.
- - Safety and ease of use
- - Features such as liquid monitoring, foam and clot detection, integrated HEPA filters, UV lamps, and a user-friendly interface are key factors in ensuring safe and convenient operation.
THE GENEQUALITY 2050 SYSTEM - A COMPREHENSIVE AUTOMATION SOLUTION
GENEQUALITY 2050 is the latest breakthrough in in vitro diagnostic testing, developed by AB Analitica - Italy. With a modern design and integrated advanced technologies, this system delivers a fully automated "Sample-to-result" workflow, saving time and improving accuracy.

Figure 1: The GENEQUALITY 2050 system
Full Automation
GENEQUALITY 2050 integrates all steps, from:
- - Sample extraction directly from the sample tube.
- - Dispensing and running Real-Time PCR.
- - Analysis and reporting of final results.
- - With a processing time of only < 120 minutes, you get fast and reliable results.
Flexible and Versatile
- - Extraction of 32 samples per run, a suitable and optimal throughput for laboratories. Reagents are pre-loaded in plates
- - Supports multiple sample tube sizes (tube height 65-105mm, radius 11-16mm)
- - Supports 24 different quantitative and qualitative assays
- - Integrated 4-channel Real-Time PCR system, capable of running up to 46 PCR reactions (including negative and positive controls) per run.
- - Users can choose the Extraction + PCR dispensing step or the Real-time PCR step, and extracted samples can be added while Real-time PCR is running
- - AB GENIUS REPORT 3 software with a standard curve saving function that can be used for a reagent lot.

Figure 2: AB GENIUS REPORT 3 software
User-Friendly Interface
- - Intuitive 15.6" touchscreen.
- - The AB GENIUS REPORT 3 software is easy to use, with various options that enable accurate analysis and interpretation of results.
- - Integrated internal database management system (LIMS), supporting secure data analysis and storage.

Figure 3: Interface of the AB GENIUS REPORT 3 result analysis software
Safe and Accurate
- - Sensor technology that monitors liquids and detects foam, clots, or air in samples.
- - Integrated HEPA filter and UV lamp to ensure a clean and safe working environment.
Compact Design
- - Dimensions: 96.5 x 73.0 x 72.0 cm.
- - Weight: under 100 kg.
- - Noise level: under 65 dB, ensuring a quiet working environment.
Summary Table of Selected GENEQUALITY 2050 Features:
| Criteria | Value |
| Sample-to-result time | < 120 minutes |
| Hands-on time | 5 minutes |
| Samples per run | 32 |
| Supported assays | 24 |
| Primary tube sampling | Yes |
| Safety and control | HEPA, UV, advanced sensors |
| Interface and data management | Touchscreen, LIMS |
Why Choose Genequality 2050?
GeneQuality 2050 is an optimal solution in molecular diagnostics with many outstanding advantages. It offers the perfect balance of throughput, accuracy, flexibility, and versatility, making it the ideal choice for modern laboratories.
Selected Assays Available on the GENEQUALITY 2050 System
| Sexually transmitted diseases | Transplant-related | Fungi | Antibiotic resistance genes |
| STI | BKV | Candida | Carbapenem resistance, Acinetobacter |
| HPV | CMV | Aspergillus | Colistin resistance |
| EBV |
Contact VIET HUY today to learn more about GeneQuality 2050 and take your laboratory's capabilities to the next level!
VIET HUY Technological Scientific Equipment Co., Ltd
- Phone: 0913 605 512
- Email: info@viethuy.vn
- Website: https://viethuy.vn/
Related Articles

Next-Generation Sequencing (NGS) in BRCA Mutation Analysis: The Optimal Tool for Diagnosing Hereditary Breast and Ovarian Cancer
Next-generation sequencing (NGS) helps detect BRCA mutations in hereditary breast and ovarian cancer, delivering high accuracy and improving treatment approaches.
GENEQUALITY Whole Exome Sequencing (WES) | Viet Huy
GENEQUALITY Whole Exome Sequencing (WES) is a whole exome sequencing solution developed by AB ANALITICA and CE-IVD certified under EU Regulation 2017/746 (IVDR). This product complies...

Exploring Whole Exome Sequencing (WES) - 2024: A Breakthrough Technology in Rare Disease Diagnosis and Personalized Medicine
Discover an overview of Whole Exome Sequencing (WES), an advanced genetic sequencing technology applied in rare disease diagnosis, cancer research, and personalized medicine
Need Advice on the Right Testing Solution?
Viet Huy engineers are ready to help your laboratory choose the optimal technology.